Malta - English - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - phenylephrine hydrochloride - solution for injection - phenylephrine hydrochloride 10 mmol/ml - cardiac therapy

Malta - English - Medicines Authority

beacon pharmaceuticals limited the bower 4 roundwood avenue, stockley park, heathrow, ub11 1af, united kingdom - phenylephrine hydrochloride - solution for infusion or injection - phenylephrine hydrochloride 10 mg/ml - cardiac therapy

Canada - English - Health Canada

pharma stulln inc. - phenylephrine hydrochloride - solution - 2.5% - phenylephrine hydrochloride 2.5% - mydriatics

Canada - English - Health Canada

pharma stulln inc. - phenylephrine hydrochloride; hydroxyethylcellulose - solution - 0.12%; 0.5% - phenylephrine hydrochloride 0.12%; hydroxyethylcellulose 0.5% - vasoconstrictors

Canada - English - Health Canada

mont-pharma inc - phenylephrine hydrochloride - solution - 10mg - phenylephrine hydrochloride 10mg - vasoconstrictors

Ireland - English - HPRA (Health Products Regulatory Authority)

bausch health ireland limited - phenylephrine hydrochloride - eye drops, solution - 2.5 percent weight/volume - sympathomimetics used as decongestants; phenylephrine

United States - English - NLM (National Library of Medicine)

a-s medication solutions - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride ophthalmic solution, usp 2.5% and 10%, is indicated to dilate the pupil. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [see dosage and administration (2.2)] . animal reproduction studies have not been conducted with topical phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human breast milk. because many drugs are excreted in human milk, cau

United States - English - NLM (National Library of Medicine)

a-s medication solutions - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride ophthalmic solution, usp 2.5% and 10%, is indicated to dilate the pupil. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [see dosage and administration (2.2)] . animal reproduction studies have not been conducted with topical phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human breast milk. because many drugs are excreted in human milk, cau

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - phenylephrine hydrochloride, quantity: 10 mg - injection - excipient ingredients: water for injections; sodium chloride; sodium citrate dihydrate; citric acid monohydrate; sodium metabisulfite; hydrochloric acid; sodium hydroxide - phenylephrine hydrochloride is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anaesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, or hypersensitivity. it is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anaesthesia, and as a vasoconstrictor in regional analgesia.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bausch + lomb ireland - phenylephrine hydrochloride 100 mg/ml - eye drops, solution - 100 mg/ml - phenylephrine hydrochloride 50 mg - phenylephrine